Magnesium shown to be important in prevention of pancreatic cancer

A long-term study of 66,806 men and women has found that magnesium is an important nutrient in the prevention of pancreatic cancer.

The participants were aged 50–76 years at the beginning of the Vitamins And Lifestyle Study (VITAL) which commenced in 2000. Participants were followed from 2000 to 2008. During an average of 6.8-year follow-up, 151 participants developed pancreatic cancer.

Researchers determed that for every 100mg that magnesium intake was lowered there was a 24% increase in the incidence of pancreatic cancer.

Researchers observed that cancer rates were not appreciably modified by age, gender, body mass index, or non-steroidal anti-inflammatory drug use; however, magnesium supplementation (from multivitamins or individual supplement) did lower the cancer rate of participants.

The study’s authors stated, “Findings from this prospective cohort study indicate that magnesium intake may be beneficial in terms of primary prevention of pancreatic cancer.”

Sources:, British Journal of Cancer